{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T19:09:26Z","timestamp":1775070566223,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jacl.2023.09.015","type":"journal-article","created":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T06:21:20Z","timestamp":1697091680000},"page":"e423-e429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of apolipoprotein A5 variants: A cohort of patients with severe hypertriglyceridemia from Turkiye"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3442-2423","authenticated-orcid":false,"given":"B.","family":"Cakmak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Yeral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Ozcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Pariltay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ozgul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6801-8499","authenticated-orcid":false,"given":"I.Y.","family":"Simsir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.A.","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jacl.2023.09.015_bib0001","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S2213-8587(13)70191-8","article-title":"The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management","volume":"2","author":"Hegele","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.jacl.2023.09.015_bib0002","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2018.10.006","article-title":"Severe hypertriglyceridemia is primarily polygenic","volume":"13","author":"Dron","year":"2019","journal-title":"J Clin Lipidol"},{"issue":"2","key":"10.1016\/j.jacl.2023.09.015_bib0003","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrg2481","article-title":"Plasma lipoproteins: genetic influences and clinical implications","volume":"10","author":"Hegele","year":"2009","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/j.jacl.2023.09.015_bib0004","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.atherosclerosis.2009.04.021","article-title":"Modulation of phenotypic expression of APOA5 Q97X and L242P mutations","volume":"207","author":"Charri\u00e8re","year":"2009","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.jacl.2023.09.015_bib0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(21)00046-2","article-title":"Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"9","author":"Gouni-Berthold","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jacl.2023.09.015_bib0006","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fendo.2020.00455","article-title":"Genetics of Hypertriglyceridemia","volume":"11","author":"Dron","year":"2020","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.jacl.2023.09.015_bib0007","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2796.2012.02516.x","article-title":"Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia","volume":"272","author":"Surendran","year":"2012","journal-title":"J Intern Med"},{"issue":"4","key":"10.1016\/j.jacl.2023.09.015_bib0008","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jacl.2016.02.010","article-title":"Rare genetic variants with large effect on triglycerides in subjects with a clinical diagnosis of familial vs nonfamilial hypertriglyceridemia","volume":"10","author":"de Castro-Or\u00f3s","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"5540","key":"10.1016\/j.jacl.2023.09.015_bib0009","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1064852","article-title":"An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing","volume":"294","author":"Pennacchio","year":"2001","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.jacl.2023.09.015_bib0010","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.atherosclerosis.2006.12.010","article-title":"Rare APOA5 mutations\u2013clinical consequences, metabolic and functional effects: an ENID review","volume":"194","author":"Talmud","year":"2007","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.jacl.2023.09.015_bib0011","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jacl.2015.11.007","article-title":"Rare and common variants in LPL and APOA5 in Thai subjects with severe hypertriglyceridemia: a resequencing approach","volume":"10","author":"Khovidhunkit","year":"2016","journal-title":"J Clin Lipidol"},{"issue":"5","key":"10.1016\/j.jacl.2023.09.015_bib0012","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"7","key":"10.1016\/j.jacl.2023.09.015_bib0013","first-page":"556","article-title":"Data on prevalence of dyslipidemia and lipid values in Turkey: systematic review and meta-analysis of epidemiological studies on cardiovascular risk factors","volume":"46","author":"Kay\u0131k\u00e7\u0131o\u011flu","year":"2018","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"3","key":"10.1016\/j.jacl.2023.09.015_bib0014","first-page":"236","article-title":"Lipids, lipoproteins and apolipoproteins among Turks, and impact on coronary heart disease","volume":"4","author":"Onat","year":"2004","journal-title":"Anadolu Kardiyol Derg"},{"issue":"2","key":"10.1016\/j.jacl.2023.09.015_bib0015","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jacl.2013.12.011","article-title":"Prevalence of dyslipidemia and associated risk factors in Turkish adults","volume":"8","author":"Bayram","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"10","key":"10.1016\/j.jacl.2023.09.015_bib0016","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/ATVBAHA.108.172866","article-title":"Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding","volume":"28","author":"Dorfmeister","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"10.1016\/j.jacl.2023.09.015_bib0017","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/ATVBAHA.122.318621","article-title":"Is genetic testing in hypertriglyceridemia useful?","volume":"42","author":"Hegele","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.jacl.2023.09.015_bib0018","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/ncpcardio1326","article-title":"APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia","volume":"5","author":"Wang","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"2","key":"10.1016\/j.jacl.2023.09.015_bib0019","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.atherosclerosis.2011.09.030","article-title":"Resequencing the Apolipoprotein A5 (APOA5) gene in patients with various forms of hypertriglyceridemia","volume":"219","author":"Evans","year":"2011","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.jacl.2023.09.015_bib0020","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/j.jacl.2023.09.015_bib0021","first-page":"232","article-title":"Ein fall von lipaemie","volume":"1","author":"Speck","year":"1865","journal-title":"Arch Verin Wiss Heilkd"},{"issue":"Suppl 1","key":"10.1016\/j.jacl.2023.09.015_bib0022","first-page":"31","article-title":"Treatment options for severe hypertriglyceridemia (SHTG): the role of apheresis","volume":"7","author":"Ewald","year":"2012","journal-title":"Clin Res CardiolSuppl"},{"issue":"1","key":"10.1016\/j.jacl.2023.09.015_bib0023","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5543\/tkda.2022.98544","article-title":"Genetic variants associated with severe hypertriglyceridemia: LPL, APOC2, APOA5, GPIHBP1, LMF1, and APOE","volume":"51","author":"Abedi","year":"2023","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"9","key":"10.1016\/j.jacl.2023.09.015_bib0024","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2017.0972","article-title":"Association of rare and common variation in the lipoprotein lipase gene with coronary artery disease","volume":"317","author":"Khera","year":"2017","journal-title":"JAMA"},{"issue":"7537","key":"10.1016\/j.jacl.2023.09.015_bib0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature13917","article-title":"Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction","volume":"518","author":"Do","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jacl.2023.09.015_bib0026","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jacl.2020.11.010","article-title":"Measurement of apolipoprotein B levels helps in the identification of patients at risk for hypertriglyceridemic pancreatitis","volume":"15","author":"Gonzales","year":"2021","journal-title":"J Clin Lipidol"},{"issue":"12","key":"10.1016\/j.jacl.2023.09.015_bib0027","doi-asserted-by":"crossref","first-page":"e13345","DOI":"10.1111\/eci.13345","article-title":"Evaluation of the chylomicron-TG to VLDL-TG ratio for type I hyperlipoproteinemia diagnostic","volume":"50","author":"Rioja","year":"2020","journal-title":"Eur J Clin Invest"},{"issue":"4","key":"10.1016\/j.jacl.2023.09.015_bib0028","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1373\/clinchem.2009.136994","article-title":"Association of apolipoprotein B with incident type 2 diabetes in an aboriginal Canadian population","volume":"56","author":"Ley","year":"2010","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.jacl.2023.09.015_bib0029","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jcem.86.3.7304","article-title":"Clinical review 124: diabetic dyslipidemia: causes and consequences","volume":"86","author":"Goldberg","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jacl.2023.09.015_bib0030","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.ATV.0000153087.36428.dd","article-title":"Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia","volume":"25","author":"Oliva","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423002799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287423002799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T04:12:40Z","timestamp":1735531960000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287423002799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1933287423002799"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2023.09.015","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of apolipoprotein A5 variants: A cohort of patients with severe hypertriglyceridemia from Turkiye","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2023.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of National Lipid Association.","name":"copyright","label":"Copyright"}]}}